ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 311

The DEK Autoantigen Regulates Formation of Neutrophil Extracellular Traps and Zymosan Induced Arthritis in Mice

Nirit Mor-Vaknin1, Anjan K. Saha2, Maureen Legendre1, Marta J. Gonzalez-Hernandez3, M. Asif Amin4, Bradley J. Rabquer5, Julie M. Jorns6, Mariana J. Kaplan7, Barbara S. Adams8, David A. Fox9, Alisa E. Koch10 and David Markovitz1, 1Internal Medicine, University of Michigan, Ann Arbor, MI, 2Medical School, University of Michigan, Ann Arbor, MI, 3Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, 4Department of Medicine, University of Michigan Medical School, Ann Arbor, MI, 5University of Michigan Medical School, Ann Arbor, MI, 6Pathology, Ann Arbor, MI, 7Systemic Autoimmunity Branch, National Institutes of Health/NIAMS, Bethesda, MD, 8University of Michigan, Ann Arbor, MI, 9Rheumatology/Int Medicine, Univ of Michigan Med Ctr, Ann Arbor, MI, 10Internal Medicine - Rheumatology, University of Michigan Medical School, Ann Arbor, MI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, juvenile idiopathic arthritis (JIA) and neutrophils

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: The nuclear oncoprotein DEK is a known autoantigen associated with juvenile idiopathic arthritis (JIA) and other autoimmune diseases. DEK is actively secreted by human macrophages and serves as chemoattractant for leukocytes, including neutrophils and T cells. We have previously demonstrated that DEK and anti-DEK autoantibodies are abundant in the inflamed synovia of JIA patients.  Postranslational modification, particularly acetylation, of DEK markedly increases its autoantigenicity, suggesting an active role for DEK and DEK autoantibodies in the inflamed joint. Using zymosan induced arthritis (ZIA) mouse model, we demonstrate that DEK contributes to the development of inflammatory arthritis by recruiting neutrophils to the joint. Remarkably, DEK also appeared to be required for the formation of neutrophil extracellular traps (NETs) and is detected in association with known NET markers in human neutrophils from synovial fluids of JIA patients.

Methods: We investigated the role of DEK using the ZIA mouse model, comparing 129/B6 wild type (WT) to DEK knockout (DEK KO) mice. Zymosan A from Saccharomyces cerevisiae, or an equal amount of sterile saline, was injected through the suprapatellar ligament into the joint cavity of WT and DEK KO mice. Inflammatory cytokines in the joint tissue homogenates were detected by ELISA. Neutrophils from healthy volunteers were purified by centrifugation over a discontinuous Histopaque gradient. Synovial fluid neutrophils from JIA patients and mouse bone marrow neutrophils were isolated in a similar manner.  The Transwell system was used for chemotaxis assays.  The neutrophil markers Ly6G, elastase and DEK and were detected by immunoflorescence and confocal microscopy.

Results: Significant levels of DEK were found in NETs from JIA synovial neutrophils. In the ZIA mouse model, DEK KO mice displayed significantly less inflammation in the joints compare to WT. Substantially reduced levels of pro-inflammatory cytokines were detected in zymosan injected joints from DEK KO vs. WT mice. Neutrophil migration into the injected joints was markedly lower in DEK KO vs. WT mice and DEK KO neutrophils demonstrated defects in NETs formation in response to lipopolysaccharide (LPS) and Escherichia coli.

Conclusion: Extracellular DEK found in the supernatant of activated primary human neutrophils serves as a chemoattractant and is important for NET formation. DEK is also detected in NETs produced by synovial fluid neutrophils of JIA patients.  These results demonstrate that the nuclear autoantigen DEK plays a major role in the development of inflammation in the joints, suggesting an active role for DEK in the development of JIA as well as other autoimmune diseases.


Disclosure:

N. Mor-Vaknin,
None;

A. K. Saha,
None;

M. Legendre,
None;

M. J. Gonzalez-Hernandez,
None;

M. A. Amin,
None;

B. J. Rabquer,
None;

J. M. Jorns,
None;

M. J. Kaplan,
None;

B. S. Adams,
None;

D. A. Fox,
None;

A. E. Koch,
None;

D. Markovitz,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-dek-autoantigen-regulates-formation-of-neutrophil-extracellular-traps-and-zymosan-induced-arthritis-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology